SouthState Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SouthState Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-240	Closed	-$19.5K	–	1832
2025 Q1	$19.5K	Buy	+240	New	+$21.5K	﹤0.01%	695
2023 Q2	–	Sell	-951	Closed	-$72.5K	–	650
2023 Q1	$72.5K	Hold	951	–	–	0.01%	340
2022 Q4	$78.9K	Sell	951 -449	-32%	-$36.4K	0.01%	352
2022 Q3	$111K	Hold	1,400	–	–	0.01%	303
2022 Q2	$104K	Buy	1,400 +450	+47%	+$33.8K	0.01%	320
2022 Q1	$85K	Buy	950 +840	+764%	+$77.6K	0.01%	387
2021 Q4	$12K	Buy	+110	New	+$13.3K	﹤0.01%	550

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

SouthState Corp's XBI Position: Q2 2025 in Review

SouthState Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 240 shares — an estimated $19.5K sold.

SouthState Corp first reported a position in XBI in Q4 2021 and held it in 7 quarters. The position peaked at $111K in Q3 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

SouthState Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
SouthState Corp sold 240 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $19.5K.
SouthState Corp first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 7 quarters.
SouthState Corp's State Street SPDR S&P Biotech ETF position peaked at $111K in Q3 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on SouthState Corp's 13F filing for Q2 2025, filed 6 Aug 2025.